化学信息:
中文名 | 酯蟾毒配基 |
英文名 | Resibufogenin |
中文别名 | 蟾力苏;布福吉宁 |
英文别名 | Bufogenin;Recibufogenin |
来源 | 黑眶蟾蜍Bufo melanostictus Schneider;中华大蟾蜍Bufo gargarizans |
化合物类型 | 甾体类(Steroids)>蟾毒配基>蟾蜍甾二烯类 |
化学式 | C24H32O4 |
分子量 | 384.51 |
CAS号 | 465-39-4 |
纯度 | 98%, HPLC |
溶剂/溶解度 | DMSO:100 mg/ml (260.07 mM) |
溶液配制 | 5mg加入1.30ml DMSO,或者每3.85mg加入1ml DMSO,配制成10mM溶液。 |
生物信息
产品描述 | Resibufogenin, a component of huachansu, has been shown to exhibit the anti-proliferative effect against cancer cells, and this may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3β. | ||||
信号通路 | - | ||||
靶点 | GSK-3β | Cyclin D1 | - | - | - |
IC50 | - | - | - | - | - |
体外研究 | The effects of Resibufogenin on the outward delayed rectifier potassium current (IK) and outward transient potassium current (IA) in rat hippocampal neurons was investigated, and it inhibited both IK and IA, at 1 μM concentration RBG could alter some channel kinetics and gating properties of IK, such as steady-state activation and inactivation curves, open probability and time constants. | ||||
体内研究 | Resibufogenin prevented evidence of oxidative stress in "preeclamptic" rats. | ||||
临床实验 | N/A |
1. Hao S, et al. Toxicol In Vitro. 2011,25(8):1644-53.
2. Uddin MN, et al. Hypertens Pregnancy. 2012,31(1):70-8.
3. Ichikawa M, et al. PLoS One. 2015,10(6):e0129851.
4. Hao S, et al. Neurosci Lett. 2011,501(2):112-6.
5. Zheng J, et al. Nat Prod Commun. 2011,6(11):1581-4.
包装清单:产品编号 | 产品名称 | 包装 |
SM7008-10mM | 酯蟾毒配基(98%, HPLC) | 10mM×0.2ml |
SM7008-5mg | 酯蟾毒配基(98%, HPLC) | 5mg |
SM7008-25mg | 酯蟾毒配基(98%, HPLC) | 25mg |
- | 说明书 | 1份 |
-20℃保存,至少一年有效。固体粉末4℃保存,至少一个月有效。如果溶于非DMSO溶剂,建议分装后-80℃保存,预计6个月内有效。
注意事项:本产品可能对人体有一定的毒害作用,请注意适当防护,以避免直接接触人体或吸入体内。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。